Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7129039
Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof
granted -
US 7122572
Calixpyrroles
granted -
US 7119064
Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
granted -
US 7115577
Colorectal neoplasia prophylaxis
granted -
US 7112317
Combined methods and compositions for tumor vasculature targeting and tumor treatment
granted -
US 7109179
Methods and compositions comprising DNA damaging agents and p53
granted -
US 7109188
Methods and compositions for treating atheroma, tumors and other neoplastic tissue
granted -
US 7101852
Composition and method for treatment and prevention of restenosis
granted -
US 7101557
Combined tissue factor methods for coagulation and tumor treatment
granted -
US 7094758
Apoptotic compounds
granted -
US 7094873
Polypeptide that interacts with heat shock proteins
granted -
US 7078182
TAO protein kinase polypeptides and methods of use therefor
granted -
US 7070957
STARS—a muscle-specific actin-binding protein
granted -
US 7071318
Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells
granted -
US 7067109
Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids
granted -
US 7067254
Diagnosis and treatment of inflammation and hyperactive immune conditions
granted -
US 7067256
Ribozyme mediated inactivation of the androgen receptor
granted -
US 7067111
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
granted -
US 7067633
Targeting cellular entry, cell survival, and pathogenicity by dynein light chain 1/PIN in human cells
granted -
US 7060689
Methods and compositions for delivery and retention of active agents to lymph nodes
granted -
US 7056509
Antibody methods for selectively inhibiting VEGF
granted -
US 7041784
Apoptotic compounds
expired -
US 7037583
Functionalized zirconium oxide particles
expired -
US 7033603
Drug releasing biodegradable fiber for delivery of therapeutics
expired